Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy

Jacob Siegel, Mariam Totonchy, William Damsky, +12

Journal of the American Academy of Dermatology

Bullous DisordersLymphoid NeoplasiaAnti–pd-l1 TherapyOncologyRetrospective Analysis +5

HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo

Neal Fischbach, Sofia Rozenfeld, Wei-Fang Shen, +8

Blood

Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy

Robert Lindner, Catherine Sullivan, Onyinye Offor, +8

PLoS ONE

Breast OncologyMolecular PhenotypesMedicinePathologyCancer Genomics +10

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

Julia Foldi, Andrea Silber, Emily Reisenbichler, +18

npj Breast Cancer

Safety and Effectiveness of Bevacizumab-Containing Treatment for Non–Small-Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study

Thomas J. Lynch, David R. Spigel, Julie R. Brahmer, +11

Journal of Thoracic Oncology

Non–small-cell Lung CancerOncologyBevacizumab-containing TreatmentCancer ManagementPharmacotherapy +6

Protein Kinase C-Mediated Phosphorylation of the Leukemia-Associated HOXA9 Protein Impairs Its DNA Binding Ability and Induces Myeloid Differentiation

Ulka Vijapurkar, Neal Fischbach, Wei-Fang Shen, +4

Molecular and Cellular Biology

Mixed-phenotype Acute LeukemiaImmunologyMyeloid NeoplasiaHematological MalignancyPkc Inhibition +14

Cloning of Human Microtubule-Associated Protein 1B and the Identification of a Related Gene on Chromosome 15

L L Lien, Chris A. Feener, Neal Fischbach, +1

Genomics

Chromosome 15CytogeneticsGeneticsProtein GeneticsChromosome Biology +7

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).

Edward James, Xiaopan Yao, Xiangyu Cong, +11

Journal of Clinical Oncology

Surgical OncologyDose-modified FolfirinoxPharmacotherapyMetastatic Pancreatic CancerMetronomic Chemotherapy +16

Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC

Julia Foldi, Adriana Kahn, Andrea Silber, +12

Clinical Cancer Research

Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC).

Edward James, Xiangyu Cong, Xiaopan Yao, +10

Journal of Clinical Oncology

Surgical OncologyQuantitative PharmacologyPathologyPharmacotherapyMetastatic Pancreatic Cancer +24